Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.
Greenlee W, Clader J, Asberom T, McCombie S, Ford J, Guzik H, Kozlowski J, Li S, Liu C, Lowe D, Vice S, Zhao H, Zhou G, Billard W, Binch H, Crosby R, Duffy R, Lachowicz J, Coffin V, Watkins R, Ruperto V, Strader C, Taylor L, Cox K.
Greenlee W, et al.
Farmaco. 2001 Apr;56(4):247-50. doi: 10.1016/s0014-827x(01)01102-8.
Farmaco. 2001.
PMID: 11421251
Review.